Published in J Biol Chem on May 27, 2009
Phosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cells. J Exp Med (2013) 1.96
E3 ubiquitin ligase APC/C-Cdh1 accounts for the Warburg effect by linking glycolysis to cell proliferation. Proc Natl Acad Sci U S A (2009) 1.62
Tumor glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer (2013) 1.57
The engine driving the ship: metabolic steering of cell proliferation and death. Nat Rev Mol Cell Biol (2010) 1.51
Stable isotope-resolved metabolomics and applications for drug development. Pharmacol Ther (2011) 1.29
Excitotoxic stimulus stabilizes PFKFB3 causing pentose-phosphate pathway to glycolysis switch and neurodegeneration. Cell Death Differ (2012) 1.15
Regulation of mammalian nucleotide metabolism and biosynthesis. Nucleic Acids Res (2015) 1.08
Dysregulated metabolism contributes to oncogenesis. Semin Cancer Biol (2015) 1.03
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets. Semin Cancer Biol (2015) 1.01
Endothelial PFKFB3 plays a critical role in angiogenesis. Arterioscler Thromb Vasc Biol (2014) 0.99
How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions? Oncogene (2014) 0.93
Spatial distribution of cellular function: the partitioning of proteins between mitochondria and the nucleus in MCF7 breast cancer cells. J Proteome Res (2012) 0.93
6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27. Cell Death Dis (2014) 0.90
First siRNA library screening in hard-to-transfect HUVEC cells. J RNAi Gene Silencing (2009) 0.89
Akt-dependent activation of the heart 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB2) isoenzyme by amino acids. J Biol Chem (2013) 0.85
Analysis and interpretation of transcriptomic data obtained from extended Warburg effect genes in patients with clear cell renal cell carcinoma. Oncoscience (2015) 0.84
Subcellular proteomics reveals a role for nucleo-cytoplasmic trafficking at the DNA replication origin activation checkpoint. J Proteome Res (2013) 0.83
Therapeutic targeting of replicative immortality. Semin Cancer Biol (2015) 0.83
Metabolic reprogramming of alloantigen-activated T cells after hematopoietic cell transplantation. J Clin Invest (2016) 0.83
Type 2 Diabetes Dysregulates Glucose Metabolism in Cardiac Progenitor Cells. J Biol Chem (2016) 0.82
MAPK14/p38α-dependent modulation of glucose metabolism affects ROS levels and autophagy during starvation. Autophagy (2014) 0.81
Cell cycle regulators guide mitochondrial activity in radiation-induced adaptive response. Antioxid Redox Signal (2014) 0.81
Systematic nucleo-cytoplasmic trafficking of proteins following exposure of MCF7 breast cancer cells to estradiol. J Proteome Res (2014) 0.81
Proteomics-based dissection of human endoderm progenitors by differential cell capture on antibody array. Mol Cell Proteomics (2012) 0.80
Mechanisms of regulation of PFKFB expression in pancreatic and gastric cancer cells. World J Gastroenterol (2014) 0.79
Glucose induces protein targeting to glycogen in hepatocytes by fructose 2,6-bisphosphate-mediated recruitment of MondoA to the promoter. Mol Cell Biol (2012) 0.78
Cdk5-mediated inhibition of APC/C-Cdh1 switches on the cyclin D1-Cdk4-pRb pathway causing aberrant S-phase entry of postmitotic neurons. Sci Rep (2015) 0.78
Cell metabolism sets the differences between subpopulations of satellite cells (SCs). BMC Cell Biol (2013) 0.77
Two-way communication between the metabolic and cell cycle machineries: the molecular basis. Cell Cycle (2015) 0.77
The p160/steroid receptor coactivator family: potent arbiters of uterine physiology and dysfunction. Biol Reprod (2014) 0.77
Targeting the sugar metabolism of tumors with a first-in-class 6-phosphofructo-2-kinase (PFKFB4) inhibitor. Oncotarget (2015) 0.77
Aripiprazole increases NADPH level in PC12 cells: the role of NADPH oxidase. J Neural Transm (Vienna) (2013) 0.76
Is there a link between soft drinks and erectile dysfunction? Cent European J Urol (2011) 0.76
Insulin-like growth factor binding protein-3 is a new predictor of radiosensitivity on esophageal squamous cell carcinoma. Sci Rep (2015) 0.75
p53 coordinates DNA repair with nucleotide synthesis by suppressing PFKFB3 expression and promoting the pentose phosphate pathway. Sci Rep (2016) 0.75
Glucagon induces translocation of glucokinase from the cytoplasm to the nucleus of hepatocytes by transfer between 6-phosphofructo 2-kinase/fructose 2,6-bisphosphatase-2 and the glucokinase regulatory protein. Biochim Biophys Acta (2014) 0.75
Metabolic control of the cell cycle. Cell Cycle (2015) 0.75
ER Alpha Rapid Signaling Is Required for Estrogen Induced Proliferation and Migration of Vascular Endothelial Cells. PLoS One (2016) 0.75
Loss of PFKFB4 induces cell death in mitotically arrested ovarian cancer cells. Oncotarget (2017) 0.75
PFK15, a Small Molecule Inhibitor of PFKFB3, Induces Cell Cycle Arrest, Apoptosis and Inhibits Invasion in Gastric Cancer. PLoS One (2016) 0.75
The molecular basis of targeting PFKFB3 as a therapeutic strategy against cancer. Oncotarget (2017) 0.75
The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab (2008) 18.87
Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev (1995) 13.66
Brick by brick: metabolism and tumor cell growth. Curr Opin Genet Dev (2008) 7.87
A kinetic study of pyrophosphate: fructose-6-phosphate phosphotransferase from potato tubers. Application to a microassay of fructose 2,6-bisphosphate. Eur J Biochem (1982) 6.74
Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem (1995) 6.25
Mammalian cyclin-dependent kinases. Trends Biochem Sci (2005) 5.54
CDK inhibitors: cell cycle regulators and beyond. Dev Cell (2008) 5.07
Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. Mol Biol Cell (2002) 5.06
Sequence requirements for synthetic peptide-mediated translocation to the nucleus. Mol Cell Biol (1989) 4.57
Cdk1 is sufficient to drive the mammalian cell cycle. Nature (2007) 4.26
Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J (1997) 4.17
Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev (1999) 4.07
Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1) at G1 phase. Nat Cell Biol (2004) 3.14
A centrosomal function for the human Nek2 protein kinase, a member of the NIMA family of cell cycle regulators. EMBO J (1998) 3.04
Fructose 2,6-bisphosphate, the probably structure of the glucose- and glucagon-sensitive stimulator of phosphofructokinase. Biochem J (1980) 2.79
A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase. Nature (2001) 2.48
Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells. Mol Cell Biol (1995) 2.47
Cell cycle kinases in cancer. Curr Opin Genet Dev (2007) 2.46
Deregulated degradation of the cdk inhibitor p27 and malignant transformation. Semin Cancer Biol (2003) 2.27
Requirements for Cdk7 in the assembly of Cdk1/cyclin B and activation of Cdk2 revealed by chemical genetics in human cells. Mol Cell (2007) 2.22
Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proc Natl Acad Sci U S A (1995) 2.11
A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression. Genes Dev (2006) 2.05
Control of liver 6-phosphofructokinase by fructose 2,6-bisphosphate and other effectors. Proc Natl Acad Sci U S A (1981) 1.91
Nuclear DNA polymerases and the HeLa cell cycle. J Biol Chem (1975) 1.86
High expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (iPFK-2; PFKFB3) in human cancers. Cancer Res (2002) 1.84
Isotopomer-based metabolomic analysis by NMR and mass spectrometry. Methods Cell Biol (2008) 1.84
Cytokine stimulation of aerobic glycolysis in hematopoietic cells exceeds proliferative demand. FASEB J (2004) 1.79
Regulatory mechanisms in carbohydrate metabolism. IV. Pasteur effect and Crabtree effect in ascites tumor cells. J Biol Chem (1959) 1.76
An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: role in tumor cell glycolysis and the Warburg effect. Proc Natl Acad Sci U S A (1999) 1.74
K-ras codon-specific mutations produce distinctive metabolic phenotypes in NIH3T3 mice [corrected] fibroblasts. Cancer Res (2005) 1.73
New insights into cyclins, CDKs, and cell cycle control. Semin Cell Dev Biol (2005) 1.70
Study of the fructose 6-phosphate/fructose 1,6-bi-phosphate cycle in the liver in vivo. Biochem J (1980) 1.69
Ras transformation requires metabolic control by 6-phosphofructo-2-kinase. Oncogene (2006) 1.68
Cell-free degradation of p27(kip1), a G1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome. Mol Cell Biol (1999) 1.57
PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate. Trends Biochem Sci (2001) 1.43
On the concentrations of cyclins and cyclin-dependent kinases in extracts of cultured human cells. Biochemistry (2000) 1.35
p27Kip1 metabolism: a fascinating labyrinth. Cell Cycle (2007) 1.34
Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer. Clin Cancer Res (2005) 1.26
Pasteur effect and phosphofructokinase. Curr Top Cell Regul (1974) 1.15
Fructose 2,6-bisphosphate and the control of glycolysis by growth factors, tumor promoters and oncogenes. Adv Enzyme Regul (1993) 1.14
Cells overexpressing fructose-2,6-bisphosphatase showed enhanced pentose phosphate pathway flux and resistance to oxidative stress. FEBS Lett (2000) 1.13
Glucose regulation of Saccharomyces cerevisiae cell cycle genes. Eukaryot Cell (2003) 1.10
Fructose-2,6-bisphosphate and control of carbohydrate metabolism in eukaryotes. Biofactors (1999) 1.10
The Schizosaccharomyces pombe pyp1 protein tyrosine phosphatase negatively regulates nutrient monitoring pathways. J Cell Sci (1996) 1.08
Noncatalytic requirement for cyclin A-cdk2 in p27 turnover. Mol Cell Biol (2004) 1.06
Enhancement of serum- and platelet-derived growth factor-induced cell proliferation by Necl-5/Tage4/poliovirus receptor/CD155 through the Ras-Raf-MEK-ERK signaling. J Biol Chem (2004) 1.04
Roles for fructose-2,6-bisphosphate in the control of fuel metabolism: beyond its allosteric effects on glycolytic and gluconeogenic enzymes. Adv Enzyme Regul (2006) 1.01
Spy1 enhances phosphorylation and degradation of the cell cycle inhibitor p27. Cell Cycle (2007) 1.01
Characterization of a human placental fructose-6-phosphate, 2-kinase/fructose-2,6-bisphosphatase. J Biochem (1997) 1.00
Nutrient regulation of cell cycle progression. Annu Rev Nutr (2004) 0.97
Regulation of ubiquitous 6-phosphofructo-2-kinase by the ubiquitin-proteasome proteolytic pathway during myogenic C2C12 cell differentiation. FEBS Lett (2003) 0.96
p27 Kip1 nuclear localization and cyclin-dependent kinase inhibitory activity are regulated by glycogen synthase kinase-3 in human colon cancer cells. Cell Death Differ (2008) 0.94
Oxalate inhibits renal proximal tubule cell proliferation via oxidative stress, p38 MAPK/JNK, and cPLA2 signaling pathways. Am J Physiol Cell Physiol (2004) 0.92
Nuclear calcium gradients in cultured rat hepatocytes. Am J Physiol (1991) 0.92
Crystal structure of the hypoxia-inducible form of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB3): a possible new target for cancer therapy. J Biol Chem (2005) 0.88
Molecular coordination of hepatic glucose metabolism by the 6-phosphofructo-2-kinase/fructose-2,6- bisphosphatase:glucokinase complex. Mol Endocrinol (2007) 0.88
Novel isoforms of rat brain fructose 6-phosphate 2-kinase/fructose 2,6-bisphosphatase are generated by tissue-specific alternative splicing. J Neurochem (1997) 0.87
Splice isoforms of ubiquitous 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase in human brain. Brain Res Mol Brain Res (2001) 0.85
Adenovirus-mediated overexpression of liver 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase in gluconeogenic rat hepatoma cells. Paradoxical effect on Fru-2,6-P2 levels. J Biol Chem (1995) 0.85
Identification of PRG1, a novel progestin-responsive gene with sequence homology to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. Mol Endocrinol (1997) 0.85
Evolutionary analysis of fructose 2,6-bisphosphate metabolism. IUBMB Life (2006) 0.84
Polysome translational state during the cell cycle. Eur J Biochem (1975) 0.80
Insulin induces PFKFB3 gene expression in HT29 human colon adenocarcinoma cells. Biochim Biophys Acta (2002) 0.79
Inducing cellular senescence using defined genetic elements. Methods Mol Biol (2007) 0.79
Mechanism of the bisphosphatase reaction of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase probed by (1)H-(15)N NMR spectroscopy. Biochemistry (2000) 0.78
Tissue-specific alternative splicing of rat brain fructose 6-phosphate 2-kinase/fructose 2,6-bisphosphatase. FEBS Lett (1999) 0.78
Comparative energy metabolism in cultured heart muscle and HeLa cells. J Cell Physiol (1983) 0.78
Expression and regulation of 6-phosphofructo-2-kinase/fructose- 2,6-bisphosphatase isozymes in white adipose tissue. Eur J Biochem (1999) 0.77
Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study. Lancet Oncol (2009) 8.68
Nivolumab and ipilimumab versus ipilimumab in untreated melanoma. N Engl J Med (2015) 7.51
Increased activation in the right insula during risk-taking decision making is related to harm avoidance and neuroticism. Neuroimage (2003) 4.07
Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci U S A (2001) 3.29
Role of PFKFB3-driven glycolysis in vessel sprouting. Cell (2013) 3.04
Mouse fibroblasts lacking RB1 function form spheres and undergo reprogramming to a cancer stem cell phenotype. Cell Stem Cell (2009) 2.00
Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer. Exp Mol Pathol (2009) 1.92
Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth. Mol Cancer Ther (2008) 1.89
High expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (iPFK-2; PFKFB3) in human cancers. Cancer Res (2002) 1.84
Targeting aspartate aminotransferase in breast cancer. Breast Cancer Res (2008) 1.78
Pre-Neolithic wild boar management and introduction to Cyprus more than 11,400 years ago. Proc Natl Acad Sci U S A (2009) 1.76
Transient T cell depletion causes regression of melanoma metastases. J Transl Med (2008) 1.61
The oncoprotein H-RasV12 increases mitochondrial metabolism. Mol Cancer (2007) 1.33
Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer. Mol Cancer Ther (2013) 1.19
YmoA negatively regulates expression of invasin from Yersinia enterocolitica. J Bacteriol (2003) 1.17
Anterior cingulate activation in high trait anxious subjects is related to altered error processing during decision making. Biol Psychiatry (2004) 1.16
Early growth response genes regulate B cell development, proliferation, and immune response. J Immunol (2008) 1.14
Disruption of inducible 6-phosphofructo-2-kinase ameliorates diet-induced adiposity but exacerbates systemic insulin resistance and adipose tissue inflammatory response. J Biol Chem (2009) 1.14
Phase I/II and pharmacodynamic study of dovitinib (TKI258), an inhibitor of fibroblast growth factor receptors and VEGF receptors, in patients with advanced melanoma. Clin Cancer Res (2011) 1.13
Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation. J Transl Med (2012) 1.13
Trauma exposure, branch of service, and physical injury in relation to mental health among U.S. veterans returning from Iraq and Afghanistan. Mil Med (2009) 1.10
Interaction trial between artemether-lumefantrine (Riamet) and quinine in healthy subjects. J Clin Pharmacol (2002) 1.10
Inhibition-related activity in subgenual cingulate is associated with symptom severity in major depression. Psychiatry Res (2009) 1.04
Deletions of the RUNX2 gene are present in about 10% of individuals with cleidocranial dysplasia. Hum Mutat (2010) 1.00
Selective effects of social anxiety, anxiety sensitivity, and negative affectivity on the neural bases of emotional face processing. Neuroimage (2011) 1.00
fMRI differences between subjects with low and high responses to alcohol during a stop signal task. Alcohol Clin Exp Res (2011) 0.98
Depletion of ascorbic acid restricts angiogenesis and retards tumor growth in a mouse model. Neoplasia (2007) 0.97
Targeted disruption of inducible 6-phosphofructo-2-kinase results in embryonic lethality. Biochem Biophys Res Commun (2005) 0.95
The role of MAPKs in B cell receptor-induced down-regulation of Egr-1 in immature B lymphoma cells. J Biol Chem (2006) 0.93
Molecular pathways: regulation of metabolism by RB. Clin Cancer Res (2012) 0.92
Phase II trial of the regulatory T cell-depleting agent, denileukin diftitox, in patients with unresectable stage IV melanoma. BMC Cancer (2011) 0.91
Inhibition of 6-phosphofructo-2-kinase (PFKFB3) induces autophagy as a survival mechanism. Cancer Metab (2014) 0.89
Greater anterior insula activation during anticipation of food images in women recovered from anorexia nervosa versus controls. Psychiatry Res (2013) 0.88
Altered brain response for semantic knowledge in Alzheimer's disease. Neuropsychologia (2010) 0.88
The ZEB1 transcription factor acts in a negative feedback loop with miR200 downstream of Ras and Rb1 to regulate Bmi1 expression. J Biol Chem (2013) 0.87
Novel immunotherapeutic agents and small molecule antagonists of signalling kinases for the treatment of metastatic melanoma. Drugs (2011) 0.86
Posttraumatic stress disorder following traumatic injury: narratives as unconscious indicators of psychopathology. Bull Menninger Clin (2008) 0.85
Increased functional brain response during word retrieval in cognitively intact older adults at genetic risk for Alzheimer's disease. Neuroimage (2010) 0.85
The compartmentalization and translocation of the sphingosine kinases: mechanisms and functions in cell signaling and sphingolipid metabolism. Crit Rev Biochem Mol Biol (2011) 0.85
Third cranial nerve palsy caused by intracranial extension of a sino-orbital natural killer T-cell lymphoma. J Neuroophthalmol (2008) 0.84
Sequential inductions of the ZEB1 transcription factor caused by mutation of Rb and then Ras proteins are required for tumor initiation and progression. J Biol Chem (2013) 0.84
Waiting for radiotherapy a national call for ethical discourse on waiting lists in radiotherapy: findings from a preliminary survey. Strahlenther Onkol (2005) 0.83
Emerging strategies in regulatory T-cell immunotherapies. Clin Adv Hematol Oncol (2009) 0.83
Estradiol stimulates glucose metabolism via 6-phosphofructo-2-kinase (PFKFB3). J Biol Chem (2014) 0.83
The effects of loss versus alteration of consciousness on inhibition-related brain activity among individuals with a history of blast-related concussion. Psychiatry Res (2010) 0.82
Combat-exposed war veterans at risk for suicide show hyperactivation of prefrontal cortex and anterior cingulate during error processing. Psychosom Med (2012) 0.82
Virus detection and identification using random multiplex (RT)-PCR with 3'-locked random primers. Virol J (2007) 0.82
Celiac disease in children, adolescents, and young adults with autoimmune thyroid disease. J Pediatr (2010) 0.82
The Rb/E2F pathway and Ras activation regulate RecQ helicase gene expression. Biochem J (2008) 0.82
Cytochrome c oxidase is activated by the oncoprotein Ras and is required for A549 lung adenocarcinoma growth. Mol Cancer (2012) 0.81
Improvement in iodine status of pregnant Australian women 3 years after introduction of a mandatory iodine fortification programme. Prev Med (2013) 0.80
Antenatal shared care: are pregnant women being adequately informed about iodine and nutritional supplementation? Aust N Z J Obstet Gynaecol (2014) 0.80
Maternal and neonatal profile and immediate outcome in extremely low birth weight babies in Delhi. Trop Doct (2004) 0.79
Rb1 family mutation is sufficient for sarcoma initiation. Nat Commun (2013) 0.79
Introduction: emerging themes in DNA topoisomerase research. Methods Mol Biol (2009) 0.78
Documenting the prominence of forensic neuropsychology at national meetings and in relevant professional journals from 1990 to 2000. Clin Neuropsychol (2002) 0.78
Cloning and chromosomal characterization of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 gene (PFKFB3, iPFK2). Int J Oncol (2003) 0.78
Block copolymer micelles for controlled delivery of glycolytic enzyme inhibitors. Pharm Res (2011) 0.77
Assaying topoisomerase II checkpoints in yeast. Methods Mol Biol (2009) 0.77
Crisis visits and psychiatric hospitalizations among patients attending a community clinic in rural Southern California. Community Ment Health J (2010) 0.77
Ethnicity and use of alternative products in psychiatric patients. Psychosomatics (2006) 0.77
Maternal and neonatal profile and immediate outcome in ELBW babies. Indian Pediatr (2003) 0.77
Why self-report "Likert" scale data should not be log-transformed. J Sports Sci (2007) 0.77
Improvement in Depressive Symptoms Among Hispanic/Latinos Receiving a Culturally Tailored IMPACT and Problem-Solving Intervention in a Community Health Center. Community Ment Health J (2014) 0.76
Troglitazone suppresses glutamine metabolism through a PPAR-independent mechanism. Biol Chem (2015) 0.76
Accidental island voyagers--response. Science (2013) 0.75
Is postoperative stenting necessary in endoscopic dacryocystorhinostomy? Laryngoscope (2013) 0.75
An automatic female pelvic medicine and reconstructive surgery registry and complications manager developed in an electronic medical record. Female Pelvic Med Reconstr Surg (2014) 0.75
Erratum: Different thresholds of ZEB1 are required for Ras-mediated tumour initiation and metastasis. Nat Commun (2015) 0.75
Immunotherapy: Tumor-infiltrating T cells--ready for prime time in melanoma? Nat Rev Clin Oncol (2011) 0.75
Outcome of Isolated Premature Menarche: A Retrospective and Follow-Up Study. Horm Res Paediatr (2015) 0.75